Education - BioBridge Global

REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Home ▶ Products and Services ▶ Blood Services ▶ Education

Education

SBB Program - A partnership between BioBridge Global and University Hospital

The Specialist in Blood Bank Technology/Transfusion Medicine Program is a 12-month distance/online learning program designed to prepare students to assume advanced positions as technical specialists in the field of immunohematology and transfusion medicine, and is accredited by CAAHEP.

Publications

Testing and Assay Development

Sars-CoV2 Antibody Testing: A Comparison of Two Assay Platforms to Designate Convalescent Plasma as High Titer

Quesada et al.

Cold-Stored Platelets

Cold Stored Platelets: One-year Experience

Gomez Ngamsuntikul et al.

Cold-stored platelets: A product with function optimized for hemorrhage control

Reddoch-Cardenas et al.

Cold platelets for trauma-associated bleeding: regulatory approval, accreditation approval, and practice implementation-just the “tip of the iceberg”

Stubbs et al.

Effects of storage time prolongation on in vivo and in vitro characteristics of 4°C-stored platelets

Stolla et al.

Therapeutic Utility of Cold-Stored Platelets or Cold-Stored Whole Blood for the Bleeding Hematology-Oncology Patient

Scorer et al.

An in vitro pilot study of apheresis platelets collected on Trima Accel system and stored in T-PAS+ solution at refrigeration temperature (1-6°C)

Reddoch-Cardenas et al.

Platelets stored at 4°C contribute to superior clot properties compared to current standard-of-care through fibrin-crosslinking

Nair et al.

Blood Products, Blood Collections and Processing

Successful Deployment of Continuity of Operations during Record Snowfall in South Texas

Quesada et al.

Cold Stored Platelets: One-year Experience

Gomez Ngamsuntikul et al.

COVID-19 Convalescent Plasma: One-year Experience

Gomez Ngamsuntikul et al.

COVID-19 Antibody Testing as a Recruitment Strategy for COVID-19 Convalescent Plasma Donors

Gomez Ngamsuntikul et al.

Low-Titer O Whole Blood

Whole blood for hemostatic resuscitation of major bleeding

Spinella et al.

Prehospital low-titer cold-stored whole blood: Philosophy for ubiquitous utilization of O-positive product for emergency use in hemorrhage due to injury

McGinity et al.

Immunoglobulin M anti-A and anti-B titers in South Texas group O D+ male donors

Beddard et al.

Give the trauma patient what they bleed, when and where they need it: establishing a comprehensive regional system of resuscitation based on patient need utilizing cold-stored, low-titer O+ whole blood

Zhu et al.

The use of low-titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhage

Shea et al.

Whole blood for postpartum hemorrhage: early experience at two institutions

Morris et al.

Large volume transfusion with whole blood is safe compared with component therapy

Gallaher et al.

Convalescent Plasma

Sars-CoV2 Antibody Testing: A Comparison of Two Assay Platforms to Designate Convalescent Plasma as High Titer

Quesada et al.

COVID-19 Convalescent Plasma: One-year Experience

Gomez Ngamsuntikul et al.

COVID-19 Antibody Testing as a Recruitment Strategy for COVID-19 Convalescent Plasma Donors

Gomez Ngamsuntikul et al.

Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

Joyner et al.

A Review on Currently Available Potential Therapeutic Options for COVID-19

Moghadam

Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients

Abdollahi et al.

Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Salazar et al.